PainReform Ltd. (NASDAQ:PRFX – Get Free Report) was the target of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 63,000 shares, a growth of 85.3% from the February 13th total of 34,000 shares. Based on an average daily volume of 3,210,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 7.4% of the company’s shares are sold short.
PainReform Stock Performance
PRFX traded up $0.14 during trading on Friday, reaching $2.79. The company had a trading volume of 73,408 shares, compared to its average volume of 1,102,021. The firm’s 50-day simple moving average is $3.10 and its 200 day simple moving average is $2.95. The company has a market cap of $2.44 million, a price-to-earnings ratio of -0.02 and a beta of 0.61. PainReform has a 12-month low of $1.73 and a 12-month high of $61.20.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in PainReform stock. Apollon Wealth Management LLC acquired a new position in PainReform Ltd. (NASDAQ:PRFX – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 12,917 shares of the company’s stock, valued at approximately $43,000. Apollon Wealth Management LLC owned 9.23% of PainReform as of its most recent filing with the SEC. Hedge funds and other institutional investors own 37.28% of the company’s stock.
PainReform Company Profile
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations.
Featured Stories
- Five stocks we like better than PainReform
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Want to Profit on the Downtrend? Downtrends, Explained.
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How to Use Stock Screeners to Find Stocks
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for PainReform Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PainReform and related companies with MarketBeat.com's FREE daily email newsletter.